Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib may effectively treat oral lichen planus.

A new AIRE gene mutation causes rare autoimmune symptoms in a Lebanese boy.

Oral retinoids are effective for treating severe skin disorders but have reversible side effects and risks for pregnant women.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

Acitretin moderately improved skin and eye issues but not hair loss or light sensitivity in a 3-year-old with IFAP syndrome.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

RXR-alpha is strongly expressed in both normal and psoriatic skin and may help in skin cell differentiation and hair growth.

Platelet-Rich Plasma (PRP) helps reduce jaw pain and improve function in young adults with mild TMJ disorder.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

Combination therapy effectively regrows hair and reduces severity in Black children with stubborn Alopecia Areata.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

JAK inhibitors like baricitinib and ritlecitinib are effective new treatments for severe alopecia areata.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.

Acrodermatitis enteropathica can be linked to dental issues, so thorough dental exams are important.

JAK inhibitors do not increase cancer risk in severe alopecia areata compared to traditional treatments.

Many children with alopecia areata also have other autoimmune diseases.

The project highlights the importance of early diagnosis and patient advocacy in managing Systemic Lupus Erythematosus.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

A child with a rare type of rickets showed some improvement with high doses of vitamin D, but such conditions often respond poorly to treatment.

TB lymphadenitis can occur in people with weakened immune systems, like those with SLE.

Defective repair processes may cause immune activation and inflammation in psoriatic disease.

Diagnosing and treating rapidly worsening lung disease is difficult and requires better guidelines and understanding.

A 16-year-old boy with lupus had a rare brain artery issue but fully recovered with treatment.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

Higher EULAR/ACR scores in SLE patients predict more organ damage.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Recognizing unusual symptoms in Crohn's disease is crucial for proper treatment.